aminophylline 250 mg10 ml
teva pharmaceutical industries ltd, israel - aminophylline - solution for injection - aminophylline 250 mg / 10 ml - aminophylline - aminophylline - for symptomatic relief or prevention of bronchial asthma and for treatment of reversible bronchospasm associated with chronic bronchitis and emphysema.
accolate tablets 40 mg milligram
astrazeneca uk limited - zafirlukast - tablets - 40 mg milligram
aridol mannitol powder for inhalation composite pack
btc speciality health pty ltd - mannitol, quantity: 0 mg - capsule, hard - excipient ingredients: gelatin - aridol is indicated for identifying bronchial hyperresponsiveness to assist in the diagnosis of asthma.
asasantin sr
boehringer ingelheim pty ltd - dipyridamole; aspirin -
coumadin 1 mg
taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 1 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
coumadin 2 mg
taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 2 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonar embolism. coumadin is indicated for the prophylaxis and/or treatment of the tromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
coumadin 2.5 mg
taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 2.5 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
coumadin 5 mg
taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 5 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonar embolis. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
aminophylline hydrate 25mg/ml solution for injection
mercury pharmaceuticals (ireland) ltd - aminophylline hydrate - solution for injection - 25 milligram(s)/millilitre - xanthines; aminophylline
warfant 1 mg tablets
mercury pharmaceuticals (ireland) ltd - warfarin sodium - tablet - 1 milligram(s) - vitamin k antagonists; warfarin